P‐gp was active in P‐gp‐positive t(17;19)‐ALL cell lines, as we found that inhibitors for P‐gp such as CyA and nilotinib intensified CAM staining and antileukemic activities of VCR and DNR. This evidence concerns the gene PGP and acute lymphoblastic leukemia.